Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis

Bonovas, Stefanos;Danese, Silvio;
2020-01-01

2020
IBD
Immunosuppression
NMSC
Small Molecule
Arthritis, Rheumatoid
Azetidines
Herpes Zoster
Heterocyclic Compounds, 3-Ring
Humans
Incidence
Inflammatory Bowel Diseases
Janus Kinase Inhibitors
Janus Kinases
Piperidines
Placebos
Psoriasis
Pyridines
Pyrimidines
Pyrroles
Randomized Controlled Trials as Topic
Spondylitis, Ankylosing
Sulfonamides
Survival Analysis
Treatment Outcome
Triazoles
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11699/55942
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact